高级检索
当前位置: 首页 > 详情页

Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303) (ALTER0303)

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究单位: [1]Chia Tai Tianqing Pharmaceutical Group Co., Ltd. [2]Capital Medical University, Beijing Chest Hospital Beijing, Beijing, China [3]Chinese Academy of Medical Sciences Cancer Hospital Beijing, Beijing, China [4]Peking Union Medical College Hospital Beijing, Beijing, China [5]Chongqing Cancer Hospital Chongqing, Chongqing, China [6]Xinqiao Hospital Chongqing, Chongqing, China [7]Fujian Province Tumor Hospital Fuzhou, Fujian, China [8]Gansu Province Tumor Hospital Lanzhou, Gansu, China [9]Gansu Provincial People 's Hospital Lanzhou, Gansu, China [10]Lanzhou Military General Hospital Lanzhou, Gansu, China [11]First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China [12]First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China [13]Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China [14]Harbin medical university affiliated tumor hospita Harbin, Heilongjiang, China [15]Henan Province Tumor Hospital Luoyan, Henan, China [16]Hunan Province Tumor Hospital Changsha, Hunan, China [17]Xiangya Hospital Central South University Changsha, Hunan, China [18]Lianyungang First People 's Hospital Lianyungang, Jiangsu, China [19]Xuzhou Medical College Hospital Xuzhou, Jiangsu, China [20]Jiangxi Province Tumor Hospital Nanchang, Jiangxi, China [21]Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China [22]Jilin Province Tumor Hospital Changchun, Jilin, China [23]Liaoning Provincial Tumor Hospital Shenyang, Liaoning, China [24]Qilu Hospital,Shandong University Jinan, Shandong, China [25]Shandong Province Tumor Hospital Jinan, Shandong, China [26]Linyi City Tumor Hospita Linyi, Shandong, China [27]Chest hospital affiliated to Shanghai jiaotong university Shanghai, Shanghai, China, 200000 [28]Cancer Hospital of Fudan University Shanghai, Shanghai, China [29]Shanghai Changhai Hospital Shanghai, Shanghai, China [30]Xinhua hospital affiliated to Shanghai jiaotong university Shanghai, Shanghai, China [31]First Affiliated Hospital of Xi'an Jiaotong University Xian, Shanxi, China [32]Tang Du Hospital Xian, Shanxi, China [33]West China Hospital , Sichuan University Chengdu, Sichuan, China [34]Sichuan Cancer Hospital Chongqing, Sichuan, China [35]20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital . Tianjin, Tianjin, China, 300600 [36]Tianjin Medical University General Hospital Tianjin, Tianjin, China [37]Yunnan Province Tumor Hospital Kunming, Yunnan, China [38]The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China [39]The Second Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China [40]Zhejiang Province Tumor Hospital Hangzhou, Zhejiang, China [41]Beijing Friendship Hospital, Capital Medical University Beijing, Beijing, China

关键词: anlotinib Cancer NSCLC Non-small Cell Lung Cancer

研究目的:
Evaluate the efficacy and safety of Anlotinib as the 3-line treatment of patients with advanced non-small lung cancer, with placebo control.

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号